| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclosporin A binding | PPIAL4D PPIAL4H PPIAL4E PPIAL4A PPIE PPIH PPIAL4C PPIA PPIF PPIAL4F PPIAL4G | 4.27e-16 | 24 | 217 | 11 | GO:0016018 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | PPIAL4D PPIAL4H PPIAL4E PPIAL4A PPIE PPIH PPIAL4C PPIA PPIF PPIAL4F PPIAL4G | 4.99e-12 | 50 | 217 | 11 | GO:0003755 |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | PPIAL4D PPIAL4H PPIAL4E PPIAL4A PPIE PPIH PPIAL4C PPIA PPIF PPIAL4F PPIAL4G | 9.90e-12 | 53 | 217 | 11 | GO:0016859 |
| GeneOntologyMolecularFunction | isomerase activity | PPIAL4D PPIAL4H BLM PPIAL4E PPIAL4A PPIE PPIH PPIAL4C PPIA PPIF PPIAL4F PUS10 PPIAL4G | 1.90e-07 | 192 | 217 | 13 | GO:0016853 |
| GeneOntologyMolecularFunction | arachidonate-CoA ligase activity | 4.22e-06 | 11 | 217 | 4 | GO:0047676 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 5.03e-06 | 41 | 217 | 6 | GO:0016877 | |
| GeneOntologyMolecularFunction | long-chain fatty acid-CoA ligase activity | 1.69e-05 | 15 | 217 | 4 | GO:0004467 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 1.95e-05 | 31 | 217 | 5 | GO:0016878 | |
| GeneOntologyMolecularFunction | amide binding | PPIAL4D PPIAL4H CLSTN2 PPIAL4E PPIAL4A PPIE PPIH PPIAL4C PPIA PPIF PPIAL4F PPIAL4G | 1.11e-04 | 299 | 217 | 12 | GO:0033218 |
| GeneOntologyMolecularFunction | pristanate-CoA ligase activity | 1.18e-04 | 2 | 217 | 2 | GO:0070251 | |
| GeneOntologyMolecularFunction | formate-tetrahydrofolate ligase activity | 1.18e-04 | 2 | 217 | 2 | GO:0004329 | |
| GeneOntologyMolecularFunction | phytanate-CoA ligase activity | 1.18e-04 | 2 | 217 | 2 | GO:0050197 | |
| GeneOntologyMolecularFunction | ligase activity | 1.24e-04 | 174 | 217 | 9 | GO:0016874 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 1.68e-04 | 26 | 217 | 4 | GO:0015645 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 1.96e-04 | 27 | 217 | 4 | GO:0016405 | |
| GeneOntologyMolecularFunction | ferric iron binding | 1.96e-04 | 11 | 217 | 3 | GO:0008199 | |
| GeneOntologyMolecularFunction | ferrous iron binding | 2.98e-04 | 30 | 217 | 4 | GO:0008198 | |
| GeneOntologyMolecularFunction | methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity | 6.95e-04 | 4 | 217 | 2 | GO:0004486 | |
| GeneOntologyMolecularFunction | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 6.95e-04 | 4 | 217 | 2 | GO:0004488 | |
| GeneOntologyMolecularFunction | POZ domain binding | 1.15e-03 | 5 | 217 | 2 | GO:0031208 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 1.43e-03 | 45 | 217 | 4 | GO:0043495 | |
| GeneOntologyMolecularFunction | ferroxidase activity | 1.71e-03 | 6 | 217 | 2 | GO:0004322 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, oxygen as acceptor | 1.71e-03 | 6 | 217 | 2 | GO:0016724 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | PPIAL4D PPIAL4H PPIAL4E PPIAL4A PPIE PPIH PPIAL4C PPIA PPIF PPIAL4F PPIAL4G | 1.34e-13 | 38 | 218 | 11 | GO:0000413 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | PPIAL4D PPIAL4H PPIAL4E PPIAL4A PPIE PPIH PPIAL4C PPIA PPIF PPIAL4F PPIAL4G | 9.18e-12 | 54 | 218 | 11 | GO:0018208 |
| GeneOntologyCellularComponent | costamere | 7.52e-05 | 22 | 220 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 2.78e-04 | 85 | 220 | 6 | GO:0000118 | |
| GeneOntologyCellularComponent | microtubule organizing center | CYLD MAPKAPK2 USP9X CEP295NL TOGARAM1 CHD3 CHD4 USP20 CEP68 STARD9 USH2A CEP85 CNTRL AKNA STIL FRY CCDC88A KIAA1217 RITA1 SMO HTT PDZD2 | 2.93e-04 | 919 | 220 | 22 | GO:0005815 |
| GeneOntologyCellularComponent | phagophore | 3.28e-04 | 3 | 220 | 2 | GO:0061908 | |
| GeneOntologyCellularComponent | centriole | 4.88e-04 | 172 | 220 | 8 | GO:0005814 | |
| HumanPheno | Orofacial cleft | ASXL1 USP9X TOGARAM1 RPS19 CHD4 POGZ BPNT2 JUP GPC3 GLI2 POMK TBX22 EVC2 BICRA STIL ORC4 PIEZO2 POMGNT2 KANSL1 FEZF1 SETD5 ANKRD17 CTBP1 SMO RAI1 | 2.60e-05 | 694 | 79 | 25 | HP:0000202 |
| HumanPheno | Craniofacial cleft | ASXL1 USP9X TOGARAM1 RPS19 CHD4 POGZ BPNT2 JUP GPC3 GLI2 POMK TBX22 EVC2 BICRA STIL ORC4 PIEZO2 POMGNT2 KANSL1 FEZF1 SETD5 ANKRD17 CTBP1 SMO RAI1 | 2.60e-05 | 694 | 79 | 25 | HP:5201015 |
| HumanPheno | Bifid uvula | USP9X CHD4 POGZ GLI2 POMK TBX22 STIL ORC4 PIEZO2 POMGNT2 SETD5 | 4.42e-05 | 167 | 79 | 11 | HP:0000193 |
| HumanPheno | Cleft soft palate | USP9X RPS19 CHD4 POGZ GLI2 POMK TBX22 BICRA STIL ORC4 PIEZO2 POMGNT2 SETD5 | 6.11e-05 | 238 | 79 | 13 | HP:0000185 |
| HumanPheno | Cleft secondary palate | USP9X RPS19 CHD4 POGZ GLI2 POMK TBX22 BICRA STIL ORC4 PIEZO2 POMGNT2 SETD5 | 6.66e-05 | 240 | 79 | 13 | HP:0410004 |
| HumanPheno | Cleft palate | ASXL1 USP9X RPS19 CHD4 POGZ BPNT2 JUP GPC3 GLI2 POMK TBX22 BICRA STIL ORC4 PIEZO2 POMGNT2 KANSL1 FEZF1 SETD5 ANKRD17 CTBP1 SMO RAI1 | 6.92e-05 | 643 | 79 | 23 | HP:0000175 |
| HumanPheno | Abnormal hard palate morphology | ASXL1 USP9X RPS19 CHD4 POGZ BPNT2 JUP GPC3 GLI2 POMK TBX22 BICRA STIL ORC4 PIEZO2 POMGNT2 KANSL1 FEZF1 SETD5 ANKRD17 CTBP1 SMO RAI1 | 7.63e-05 | 647 | 79 | 23 | HP:0100737 |
| HumanPheno | Chronic constipation | 8.51e-05 | 120 | 79 | 9 | HP:0012450 | |
| HumanPheno | Abnormal brain-evoked potentials | ASXL1 USP9X POGZ SUCLA2 GPC3 ATXN1 POMK EVC2 LAMA2 FXN PIEZO2 TNFSF11 POMGNT2 | 8.60e-05 | 246 | 79 | 13 | HP:0430106 |
| HumanPheno | Cleft upper lip | 1.02e-04 | 183 | 79 | 11 | HP:0000204 | |
| HumanPheno | Abnormal soft palate morphology | USP9X RPS19 CHD4 POGZ GLI2 POMK TBX22 BICRA STIL ORC4 PIEZO2 POMGNT2 SETD5 RAI1 | 1.14e-04 | 289 | 79 | 14 | HP:0100736 |
| Domain | Cyclophilin-type_PPIase_CS | 2.41e-13 | 19 | 214 | 9 | IPR020892 | |
| Domain | Cyclophilin-type_PPIase | 7.50e-13 | 21 | 214 | 9 | IPR024936 | |
| Domain | Pro_isomerase | 1.26e-12 | 22 | 214 | 9 | PF00160 | |
| Domain | Cyclophilin-type_PPIase_dom | 1.26e-12 | 22 | 214 | 9 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 1.26e-12 | 22 | 214 | 9 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 1.26e-12 | 22 | 214 | 9 | PS50072 | |
| Domain | - | 1.26e-12 | 22 | 214 | 9 | 2.40.100.10 | |
| Domain | CSA_PPIASE_1 | 1.26e-12 | 22 | 214 | 9 | PS00170 | |
| Domain | Formate_THF_ligase | 1.31e-04 | 2 | 214 | 2 | IPR000559 | |
| Domain | FTHFS_2 | 1.31e-04 | 2 | 214 | 2 | PS00722 | |
| Domain | FTHFS_1 | 1.31e-04 | 2 | 214 | 2 | PS00721 | |
| Domain | FTHFS | 1.31e-04 | 2 | 214 | 2 | PF01268 | |
| Domain | Formate_THF_ligase_CS | 1.31e-04 | 2 | 214 | 2 | IPR020628 | |
| Domain | ATG2 | 1.31e-04 | 2 | 214 | 2 | IPR026849 | |
| Domain | ATG2_CAD | 1.31e-04 | 2 | 214 | 2 | PF13329 | |
| Domain | ATG2_CAD_motif | 1.31e-04 | 2 | 214 | 2 | IPR026885 | |
| Domain | ANK_REPEAT | TRPV2 ANKDD1B ZDHHC13 ANKFY1 ANK2 ANK3 MUC16 LRRK1 ANKRD50 ANKRD17 ANKRD24 | 1.68e-04 | 253 | 214 | 11 | PS50088 |
| Domain | ANK_REP_REGION | TRPV2 ANKDD1B ZDHHC13 ANKFY1 ANK2 ANK3 MUC16 LRRK1 ANKRD50 ANKRD17 ANKRD24 | 1.74e-04 | 254 | 214 | 11 | PS50297 |
| Domain | Ank_2 | TRPV2 ANKDD1B ZDHHC13 ANKFY1 ANK2 ANK3 LRRK1 ANKRD50 ANKRD17 ANKRD24 | 1.94e-04 | 215 | 214 | 10 | PF12796 |
| Domain | AMP-binding_CS | 2.06e-04 | 26 | 214 | 4 | IPR020845 | |
| Domain | AMP_BINDING | 2.77e-04 | 28 | 214 | 4 | PS00455 | |
| Domain | AMP-binding | 3.64e-04 | 30 | 214 | 4 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 3.64e-04 | 30 | 214 | 4 | IPR000873 | |
| Domain | HARE-HTH | 3.89e-04 | 3 | 214 | 2 | PF05066 | |
| Domain | ASXH | 3.89e-04 | 3 | 214 | 2 | PF13919 | |
| Domain | PHD_3 | 3.89e-04 | 3 | 214 | 2 | PF13922 | |
| Domain | AXH | 3.89e-04 | 3 | 214 | 2 | SM00536 | |
| Domain | ASX-like_PHD | 3.89e-04 | 3 | 214 | 2 | IPR026905 | |
| Domain | CHD_N | 3.89e-04 | 3 | 214 | 2 | IPR012958 | |
| Domain | CHD_C2 | 3.89e-04 | 3 | 214 | 2 | IPR012957 | |
| Domain | ASXH | 3.89e-04 | 3 | 214 | 2 | IPR028020 | |
| Domain | AXH | 3.89e-04 | 3 | 214 | 2 | PF08517 | |
| Domain | Ataxin_AXH_dom | 3.89e-04 | 3 | 214 | 2 | IPR003652 | |
| Domain | CHDCT2 | 3.89e-04 | 3 | 214 | 2 | PF08074 | |
| Domain | CHDNT | 3.89e-04 | 3 | 214 | 2 | PF08073 | |
| Domain | DUF1086 | 3.89e-04 | 3 | 214 | 2 | IPR009462 | |
| Domain | DUF1087 | 3.89e-04 | 3 | 214 | 2 | IPR009463 | |
| Domain | ASX/ASX-like | 3.89e-04 | 3 | 214 | 2 | IPR024811 | |
| Domain | AXH | 3.89e-04 | 3 | 214 | 2 | PS51148 | |
| Domain | HB1/Asxl_HTH | 3.89e-04 | 3 | 214 | 2 | IPR007759 | |
| Domain | DUF1087 | 3.89e-04 | 3 | 214 | 2 | PF06465 | |
| Domain | DUF1086 | 3.89e-04 | 3 | 214 | 2 | PF06461 | |
| Domain | DUF1087 | 3.89e-04 | 3 | 214 | 2 | SM01147 | |
| Domain | DUF1086 | 3.89e-04 | 3 | 214 | 2 | SM01146 | |
| Domain | - | TRPV2 ANKDD1B ZDHHC13 ANKFY1 ANK2 ANK3 LRRK1 ANKRD50 ANKRD17 ANKRD24 | 6.00e-04 | 248 | 214 | 10 | 1.25.40.20 |
| Domain | ANK | TRPV2 ANKDD1B ZDHHC13 ANKFY1 ANK2 ANK3 LRRK1 ANKRD50 ANKRD17 ANKRD24 | 6.58e-04 | 251 | 214 | 10 | SM00248 |
| Domain | Ankyrin_rpt-contain_dom | TRPV2 ANKDD1B ZDHHC13 ANKFY1 ANK2 ANK3 LRRK1 ANKRD50 ANKRD17 ANKRD24 | 7.21e-04 | 254 | 214 | 10 | IPR020683 |
| Domain | THF_DHG_CYH_C | 7.72e-04 | 4 | 214 | 2 | PF02882 | |
| Domain | THF_DH/CycHdrlase_cat_dom | 7.72e-04 | 4 | 214 | 2 | IPR020630 | |
| Domain | THF_DH/CycHdrlase_NAD-bd_dom | 7.72e-04 | 4 | 214 | 2 | IPR020631 | |
| Domain | THF_DHG_CYH | 7.72e-04 | 4 | 214 | 2 | PF00763 | |
| Domain | THF_DH/CycHdrlase | 7.72e-04 | 4 | 214 | 2 | IPR000672 | |
| Domain | ZF_PHD_2 | 7.86e-04 | 95 | 214 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 8.30e-04 | 96 | 214 | 6 | PS01359 | |
| Domain | Ankyrin_rpt | TRPV2 ANKDD1B ZDHHC13 ANKFY1 ANK2 ANK3 LRRK1 ANKRD50 ANKRD17 ANKRD24 | 9.14e-04 | 262 | 214 | 10 | IPR002110 |
| Domain | VWC_out | 1.26e-03 | 19 | 214 | 3 | SM00215 | |
| Domain | Autophagy-rel_C | 1.28e-03 | 5 | 214 | 2 | IPR015412 | |
| Domain | ATG_C | 1.28e-03 | 5 | 214 | 2 | PF09333 | |
| Domain | Ank | TRPV2 ZDHHC13 ANKFY1 ANK2 ANK3 LRRK1 ANKRD50 ANKRD17 ANKRD24 | 1.30e-03 | 228 | 214 | 9 | PF00023 |
| Domain | Rossmann-like_a/b/a_fold | 1.46e-03 | 43 | 214 | 4 | IPR014729 | |
| Domain | - | 1.46e-03 | 43 | 214 | 4 | 3.40.50.620 | |
| Pubmed | TET2 NRIP1 ZNF536 HIVEP1 CHD3 CHD4 POGZ GTF3C5 JUP GSE1 AHNAK ANKFY1 ZBTB33 CIP2A ATG2B ADNP NCOR2 CCDC88A ANKRD17 CTBP1 | 3.62e-12 | 418 | 221 | 20 | 34709266 | |
| Pubmed | CYLD TET2 ZHX3 ASXL1 ZNF536 HIVEP1 USP9X MAZ EIF3E RPS19 CHD3 POGZ BLM JUP LARP4B BRD8 GSE1 ATXN1 GLI2 SYNE2 ZNF638 MLLT6 CEP85 ZBTB33 BICRA ADNP ATXN1L ZNF3 NCOR2 KANSL1 FTH1 ANKRD17 CTBP1 USP54 RPA2 | 7.90e-12 | 1429 | 221 | 35 | 35140242 | |
| Pubmed | ZHX3 NRIP1 ZNF536 HIVEP1 USP9X GTF3C5 PLEKHH1 GSE1 CDIPT SYNE2 FER1L5 ROBO4 ANKFY1 MUC16 ALG11 NCOR2 OSBP ASXL3 DDHD1 ANKRD17 DSG4 RAI1 AHNAK2 | 2.59e-11 | 638 | 221 | 23 | 31182584 | |
| Pubmed | KIAA0408 NRIP1 DCAF6 HIVEP1 OBSCN CHD4 LARP4B GPC3 GSE1 ATXN1 SYNE2 ANKFY1 VWF ANK2 LAMA2 SEC31A ANKRD50 FTH1 TGS1 | 5.71e-10 | 497 | 221 | 19 | 23414517 | |
| Pubmed | HIVEP1 HIVEP2 POGZ JUP ATXN1 COBL VWF ANK3 KIF26B BICRA CNTRL SEC31A CCDC88A KANSL1 FTH1 ANKRD17 ANKRD24 EPAS1 | 2.71e-09 | 486 | 221 | 18 | 20936779 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD TET2 ERBB2 HIVEP1 HIVEP2 MAZ JUP PTPN14 ATXN1 STARD9 AHNAK SYNE2 COBL SASH1 KIF26B STIL CCDC88A KIAA1217 PHACTR4 ANKRD17 USP54 OTOG AHNAK2 | 8.25e-09 | 861 | 221 | 23 | 36931259 |
| Pubmed | CYLD ZHX3 ASXL1 ZNF536 POGZ PLEKHH1 GSE1 STARD9 KLHL13 COBL ADGRL3 ANKFY1 DLGAP4 KANSL1 SETD5 PDZD2 | 9.25e-09 | 407 | 221 | 16 | 12693553 | |
| Pubmed | TET2 ERBB2 TBC1D2B ADGRB3 POGZ ATG2A METAP1 SASH1 AKNA FNDC3A LRRK1 ANKRD50 ADNP CCDC88A ABCA5 DDHD1 ANKRD17 RAI1 | 1.01e-08 | 529 | 221 | 18 | 14621295 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZHX3 HIVEP1 PPIAL4D MAZ RPS19 CHD3 CHD4 POGZ BLM METAP1 JUP BRD8 AHNAK ZNF638 PPIAL4A MLLT6 ZBTB33 BICRA ADNP PPIA PPIAL4F NCOR2 PPIAL4G RAI1 | 1.21e-08 | 954 | 221 | 24 | 36373674 |
| Pubmed | ERBB2 JUP PTPN14 ZFYVE9 COBL ANK3 SASH1 DLGAP4 SLC6A15 SEC31A ANKRD50 IARS2 CCDC88A KIAA1217 PHACTR4 CTBP1 | 1.48e-08 | 421 | 221 | 16 | 36976175 | |
| Pubmed | ERBB2 USP9X ETFB RPS19 JUP AHNAK ZBTB33 ANK2 ANK3 CIP2A ATG2B FNDC3A SEC31A ANKRD50 PPIA CCDC88A MTHFD1 PHACTR4 UBA6 ANKRD17 | 3.30e-08 | 708 | 221 | 20 | 39231216 | |
| Pubmed | DDX47 CYLD ERBB2 ZNF536 DCAF6 MAZ CHD3 CHD4 CLSTN2 POGZ LARP4B BRD8 PTPN14 GSE1 ATXN1 TAF7L PPIH ZDHHC13 ZBTB33 BICRA NCOR2 SETD5 ANKRD17 USP54 RAI1 | 5.61e-08 | 1116 | 221 | 25 | 31753913 | |
| Pubmed | CYLD RPS19 CHD4 BLM AHNAK ZNF638 ZBTB33 ANK3 DSCAM CNTRL MUC16 SLC6A15 SEC31A ANKRD50 PPIA IARS2 CCDC88A MTHFD1 PHACTR4 CTBP1 | 1.48e-07 | 777 | 221 | 20 | 35844135 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DDX47 EIF3E RPS19 CHD4 POGZ GTF3C5 BLM ACSL1 ACSL3 JUP PTPN14 AHNAK ZNF638 AP1G2 PPIH ANKFY1 MTHFD1L SEC31A ADNP PAPSS2 PPIA NCOR2 KANSL1 MTHFD1 ANKRD17 RIOK2 AHNAK2 | 1.64e-07 | 1353 | 221 | 27 | 29467282 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SECISBP2L DDX47 CYLD MAPKAPK2 USP9X ETFB EIF3E TBC1D2B POGZ ATG2A GTF3C5 LARP4B AP3M2 AP1G2 CEP85 CIP2A SEC31A ANKRD50 CRY1 CCDC88A KIAA1217 RIOK2 TGS1 | 2.39e-07 | 1038 | 221 | 23 | 26673895 |
| Pubmed | CYLD USP9X ADGRB3 CHD4 SYNE2 KCNAB1 ANKFY1 ANK2 ANK3 DSCAM DLGAP4 SEC31A ADNP PPIA NCOR2 FRY CCDC88A KIAA1217 UBA6 ANKRD17 CTBP1 RAI1 | 2.66e-07 | 963 | 221 | 22 | 28671696 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NRIP1 ERBB2 DCAF6 HIVEP2 MAPKAPK2 OBSCN CHD3 SUCLA2 PLEKHH1 ATXN1 GLI2 ZNF638 COBL PPIE ZDHHC13 ANK3 BICRA NCOR2 SETD5 KIAA1217 UBA6 ANKRD17 CTBP1 ANKRD24 PRDM15 RAI1 HTT PDZD2 | 3.16e-07 | 1489 | 221 | 28 | 28611215 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 ZNF536 HIVEP1 HIVEP2 POGZ GSE1 ATXN1 BICRA ATXN1L NCOR2 ASXL3 CTBP1 RAI1 | 4.62e-07 | 351 | 221 | 13 | 38297188 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ASXL1 ZNF536 CHD4 POGZ GTF3C5 BLM BRD8 GSE1 TOMM40 ZBTB33 ADNP ORC4 NCOR2 IARS2 POMGNT2 KANSL1 RITA1 ANKRD17 RPA2 PRDM15 | 6.88e-07 | 857 | 221 | 20 | 25609649 |
| Pubmed | USP9X MAZ ETFB EIF3E CHD4 SUCLA2 GTF3C5 METAP1 ACSL3 BPNT2 JUP CDIPT TOMM40 SEC31A PPIA IARS2 MTHFD1 CTBP1 RPA2 HTT | 9.98e-07 | 878 | 221 | 20 | 37223481 | |
| Pubmed | Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. | 1.01e-06 | 4 | 221 | 3 | 16121196 | |
| Pubmed | Multiple cyclophilins involved in different cellular pathways mediate HCV replication. | 1.01e-06 | 4 | 221 | 3 | 19932913 | |
| Pubmed | CYLD USP9X ETFB ADGRB3 SUCLA2 LRP1B ACSL3 PPP1R2B LARP4B KCNAB1 PLPPR2 ADGRL3 ANK2 ANK3 DLGAP4 ATG2B PPIA PPP1R2 OSBP CCDC88A POMGNT2 MTHFD1 KIAA1217 | 1.18e-06 | 1139 | 221 | 23 | 36417873 | |
| Pubmed | TET2 ZHX3 HIVEP1 CHD3 CHD4 BRD8 GSE1 ATXN1 ZBTB33 ATXN1L RAI1 | 1.33e-06 | 268 | 221 | 11 | 33640491 | |
| Pubmed | EIF3E GTF3C5 JUP AHNAK ZBTB33 CIP2A ATG2B IARS2 ANKRD17 AHNAK2 | 1.38e-06 | 216 | 221 | 10 | 31519766 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TET2 ZHX3 NRIP1 HIVEP1 MAZ POGZ SYNE2 BICRA NCOR2 CTBP1 USP54 MYO15A RPA2 | 1.87e-06 | 398 | 221 | 13 | 35016035 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TET2 NRIP1 ETFB LARP4B PTPN14 GLI2 KAZN REV1 CEP85 SEC31A NCOR2 GZF1 KANSL1 MTHFD1 KIAA1217 | 2.04e-06 | 536 | 221 | 15 | 15840001 |
| Pubmed | 2.05e-06 | 15 | 221 | 4 | 20676357 | ||
| Pubmed | TET2 NRIP1 ETFB LARP4B PTPN14 GLI2 KAZN REV1 CEP85 SEC31A NCOR2 GZF1 KANSL1 MTHFD1 KIAA1217 | 2.14e-06 | 538 | 221 | 15 | 10512203 | |
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 2.28e-06 | 178 | 221 | 9 | 27637333 | |
| Pubmed | Ataxin-1 and Brother of ataxin-1 are components of the Notch signalling pathway. | 2.51e-06 | 5 | 221 | 3 | 21475249 | |
| Pubmed | ERBB2 OBSCN CHD4 PLEKHH1 SLC27A2 ANKFY1 ANK3 SLC6A15 FNDC3A ATXN1L CRY1 | 4.47e-06 | 304 | 221 | 11 | 32235678 | |
| Pubmed | USP9X EIF3E RPS19 CHD4 POGZ BLM ACSL3 LARP4B AHNAK SYNE2 ZNF638 MTHFD1L ADNP IARS2 ANKRD17 RAI1 | 5.07e-06 | 653 | 221 | 16 | 22586326 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | CHD3 JUP AHNAK ZBTB33 KIF26B CIP2A ATG2B CCDC88A ANKRD17 AHNAK2 | 6.27e-06 | 256 | 221 | 10 | 33397691 |
| Pubmed | CYLD TET2 NRIP1 DCAF6 HIVEP2 USP9X ADGRB3 CHD4 POGZ LRP1B PLEKHH1 METAP1 CEP85 VWF ANK2 ANK3 DSCAM SEC31A FRY HEATR6 CTBP1 ANKRD24 USP54 | 8.60e-06 | 1285 | 221 | 23 | 35914814 | |
| Pubmed | 8.69e-06 | 7 | 221 | 3 | 11121205 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 HIVEP2 IMPDH1 MAPKAPK2 OBSCN ATG2A AHNAK COBL AP1G2 MLLT6 MTHFD1L BICRA AKNA LRRK1 NCOR2 POMGNT2 KANSL1 SETD5 RAI1 HTT AHNAK2 | 8.88e-06 | 1105 | 221 | 21 | 35748872 |
| Pubmed | USP9X EIF3E CHD4 SUCLA2 GTF3C5 LARP4B PPIH ANKFY1 MTHFD1L SEC31A ADNP ORC4 MTHFD1 ANKRD17 | 9.42e-06 | 534 | 221 | 14 | 35032548 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZHX3 RPS19 CHD3 CHD4 PPP1R2B JUP GSE1 AHNAK ZNF638 ZBTB33 ANK2 ATG2B ADNP PPIA IARS2 MTHFD1 KIAA1217 ANKRD17 AHNAK2 | 9.45e-06 | 934 | 221 | 19 | 33916271 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 HIVEP1 CHD3 CHD4 POGZ BLM ACSL3 BRD8 GSE1 ZNF638 PPP1R2 NCOR2 OSBP KANSL1 PHACTR4 FTH1 ANKRD17 | 1.07e-05 | 774 | 221 | 17 | 15302935 |
| Pubmed | USP9X POGZ GTF3C5 JUP BRD8 PTPN14 AHNAK CEP85 ZBTB33 ANK3 ATG2B ADNP PHACTR4 HTT | 1.28e-05 | 549 | 221 | 14 | 38280479 | |
| Pubmed | Mammalian chromodomain proteins: their role in genome organisation and expression. | 1.38e-05 | 8 | 221 | 3 | 10655032 | |
| Pubmed | 1.52e-05 | 225 | 221 | 9 | 12168954 | ||
| Pubmed | 1.54e-05 | 83 | 221 | 6 | 28794006 | ||
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | MAPKAPK2 LARP4B AP1G2 CRYZL1 SLC27A2 CIP2A ATG2B FXN PPIF USP54 RIOK2 HTT | 1.74e-05 | 419 | 221 | 12 | 33001583 |
| Pubmed | A chemical tool for blue light-inducible proximity photo-crosslinking in live cells. | 1.81e-05 | 25 | 221 | 4 | 35211260 | |
| Pubmed | 1.90e-05 | 177 | 221 | 8 | 26206133 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DDX47 ZHX3 NRIP1 USP9X TBC1D2B OBSCN BLM COBL ANK3 MTHFD1L MTHFD1 UBA6 RAI1 | 2.02e-05 | 497 | 221 | 13 | 36774506 |
| Pubmed | DDX47 USP9X EIF3E RPS19 CHD4 ACSL1 ACSL3 BPNT2 LARP4B AHNAK CDIPT ZDHHC13 MTHFD1L CNTRL AKNA ALG11 FNDC3A PPIA NCOR2 MTHFD1 ANKRD17 | 2.02e-05 | 1168 | 221 | 21 | 19946888 | |
| Pubmed | TBR1 regulates autism risk genes in the developing neocortex. | 2.07e-05 | 9 | 221 | 3 | 27325115 | |
| Pubmed | CHD3 CHD4 ACSL3 JUP LARP4B AHNAK PAPSS2 NCOR2 ANKRD17 AHNAK2 | 2.33e-05 | 298 | 221 | 10 | 30737378 | |
| Pubmed | SECISBP2L DDX47 IMPDH1 MAZ ETFB CHD3 CHD4 POGZ SUCLA2 GTF3C5 NGRN LARP4B GPC3 STARD9 AHNAK PPIH CEP85 ANK2 GZF1 FTH1 ANKRD17 ISG20L2 RIOK2 | 2.39e-05 | 1371 | 221 | 23 | 36244648 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CYLD NRIP1 HIVEP1 USP9X TBC1D2B RPS19 BLM PTPN14 GSE1 CEP85 CIP2A NCOR2 CCDC88A KIAA1217 | 2.73e-05 | 588 | 221 | 14 | 38580884 |
| Pubmed | HIVEP1 EIF3E CHD3 METAP1 JUP ZFYVE9 EVC2 VWF ANK3 SASH1 NCOR2 KANSL1 UBA6 EPAS1 | 2.89e-05 | 591 | 221 | 14 | 15231748 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | IMPDH1 USP9X ACP5 ETFB EIF3E PTPN14 CDIPT PPIAL4A TOMM40 PPIAL4C MTHFD1L CIP2A ATG2B RDH14 ANKRD50 PPIA ORC4 CTBP1 | 3.18e-05 | 931 | 221 | 18 | 27432908 |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 28800131 | ||
| Pubmed | Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia. | 4.02e-05 | 2 | 221 | 2 | 26771811 | |
| Pubmed | Identification and characterization of two distinct PPP1R2 isoforms in human spermatozoa. | 4.02e-05 | 2 | 221 | 2 | 23506001 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 28645722 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 15611115 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 22219374 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 17322884 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 7575689 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 25758454 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 37288803 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 17324924 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 20686018 | ||
| Pubmed | SorCS2-mediated NR2A trafficking regulates motor deficits in Huntington's disease. | 4.02e-05 | 2 | 221 | 2 | 28469074 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 32460012 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 31629737 | ||
| Pubmed | TRANCE counteracts FasL-mediated apoptosis of murine bone marrow-derived dendritic cells. | 4.02e-05 | 2 | 221 | 2 | 15919368 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 32521854 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 23142774 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 21543494 | ||
| Pubmed | Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms. | 4.02e-05 | 2 | 221 | 2 | 23009937 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 25681440 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 20833135 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 20573830 | ||
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 4.02e-05 | 2 | 221 | 2 | 35568926 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 34504195 | ||
| Pubmed | Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. | 4.02e-05 | 2 | 221 | 2 | 24218140 | |
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 4.02e-05 | 2 | 221 | 2 | 7560064 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 24556084 | ||
| Pubmed | A convergent mechanism of high risk factors ADNP and POGZ in neurodevelopmental disorders. | 4.02e-05 | 2 | 221 | 2 | 35775424 | |
| Pubmed | HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer. | 4.02e-05 | 2 | 221 | 2 | 30670058 | |
| Pubmed | Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations. | 4.02e-05 | 2 | 221 | 2 | 20334914 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 11739372 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 15007166 | ||
| Pubmed | PILRα and PILRβ have a siglec fold and provide the basis of binding to sialic acid. | 4.02e-05 | 2 | 221 | 2 | 24843130 | |
| Pubmed | cDNA cloning and mRNA distribution of a mouse very long-chain acyl-CoA synthetase. | 4.02e-05 | 2 | 221 | 2 | 9559670 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 19996169 | ||
| Pubmed | The role of TET2-mediated ROBO4 hypomethylation in the development of diabetic retinopathy. | 4.02e-05 | 2 | 221 | 2 | 37430272 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 23300147 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 30454965 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 25596262 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 20065029 | ||
| Pubmed | Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex. | 4.02e-05 | 2 | 221 | 2 | 26095772 | |
| Pubmed | HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells. | 4.02e-05 | 2 | 221 | 2 | 30409762 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 11781319 | ||
| Pubmed | Structural basis of diverse membrane target recognitions by ankyrins. | 4.02e-05 | 2 | 221 | 2 | 25383926 | |
| Interaction | NR3C1 interactions | DDX47 ZHX3 NRIP1 ZNF536 DCAF6 HIVEP1 USP9X POGZ GTF3C5 PLEKHH1 ACSL1 ACSL3 GSE1 CDIPT SYNE2 FER1L5 ROBO4 ANKFY1 MUC16 ALG11 NCOR2 OSBP ASXL3 DDHD1 FTH1 ANKRD17 DSG4 RPA2 EPAS1 RAI1 AHNAK2 | 4.54e-08 | 974 | 214 | 31 | int:NR3C1 |
| Interaction | KDM1A interactions | KIAA0408 TET2 NRIP1 HIVEP1 USP9X CHD3 CHD4 POGZ GTF3C5 C4orf17 JUP GSE1 ATXN1 AHNAK AP1G2 ZNF480 ANKFY1 ZBTB33 CIP2A ATG2B ADNP NCOR2 CCDC88A KANSL1 KIAA1217 ANKRD17 CTBP1 RPA2 EPAS1 HTT | 7.41e-08 | 941 | 214 | 30 | int:KDM1A |
| Interaction | YWHAH interactions | CYLD TET2 NRIP1 HIVEP1 HIVEP2 MAZ CHRNA4 JUP PTPN14 ATXN1 STARD9 AHNAK SYNE2 ZNF638 COBL EVC2 SASH1 KIF26B CNTRL STIL ATXN1L CRY1 IARS2 CCDC88A KIAA1217 PHACTR4 ANKRD17 USP54 RPA2 HTT OTOG AHNAK2 | 2.18e-07 | 1102 | 214 | 32 | int:YWHAH |
| Interaction | HNF1B interactions | TET2 ZNF536 HIVEP1 POGZ GSE1 ATXN1 MLLT6 BICRA ATXN1L NCOR2 USP54 RPA2 | 9.34e-07 | 190 | 214 | 12 | int:HNF1B |
| Interaction | EGR2 interactions | TET2 ZNF536 HIVEP1 HIVEP2 ACP5 POGZ ATXN1 BICRA FASLG ATXN1L NCOR2 | 2.24e-06 | 171 | 214 | 11 | int:EGR2 |
| Interaction | HDAC1 interactions | TET2 ZHX3 NRIP1 ZNF536 HIVEP1 RPS19 CHD3 CHD4 JUP GSE1 ATXN1 GLI2 AHNAK SYNE2 ZNF638 POMK ANKFY1 ZBTB33 CIP2A ATG2B ADNP PPIA CRY1 NCOR2 ANKRD17 CTBP1 RPA2 EPAS1 RAI1 | 6.64e-06 | 1108 | 214 | 29 | int:HDAC1 |
| Interaction | HNF4A interactions | NRIP1 HIVEP1 CHD3 POGZ BLM BRD8 GSE1 ATXN1 BICRA ADNP NCOR2 KANSL1 TGS1 | 8.18e-06 | 275 | 214 | 13 | int:HNF4A |
| Interaction | CTNNB1 interactions | CYLD ERBB2 USP9X EIF3E CHD4 USP20 JUP PTPN14 ZFYVE9 PTPRZ1 SYNE2 PPIE ZBTB33 ANK2 ANK3 ADNP PPIA OSBP CCDC88A ABCA5 MTHFD1 KIAA1217 CTBP1 USP54 RPA2 EPAS1 HTT | 9.58e-06 | 1009 | 214 | 27 | int:CTNNB1 |
| Interaction | MYB interactions | 1.27e-05 | 133 | 214 | 9 | int:MYB | |
| Interaction | AFDN interactions | USP9X JUP PTPN14 ATXN1 JAG1 ZNF638 MLLT6 DSCAM SLC6A15 CCDC88A KIAA1217 PHACTR4 USP54 RPA2 | 1.39e-05 | 333 | 214 | 14 | int:AFDN |
| Interaction | CNOT3 interactions | SUCLA2 LARP4B ATXN1 GLI2 CEP85 STIL PPIA CCDC88A ANKRD17 RPA2 HTT | 1.39e-05 | 207 | 214 | 11 | int:CNOT3 |
| Interaction | ISOC1 interactions | 1.77e-05 | 77 | 214 | 7 | int:ISOC1 | |
| Interaction | KCNA3 interactions | NRIP1 ERBB2 ABCA13 USP9X ETFB RPS19 JUP AHNAK COBL ZBTB33 ANK2 ANK3 CIP2A ATG2B FNDC3A SEC31A ANKRD50 PPIA CCDC88A MTHFD1 PHACTR4 UBA6 ANKRD17 OTOG | 1.94e-05 | 871 | 214 | 24 | int:KCNA3 |
| Interaction | SMC5 interactions | ZHX3 HIVEP1 PPIAL4D MAZ RPS19 CHD3 CHD4 POGZ BLM METAP1 JUP BRD8 AHNAK ZNF638 PPIAL4A MLLT6 ZBTB33 BICRA CIP2A ADNP PPIA PPIAL4F NCOR2 PPIAL4G RPA2 RAI1 | 2.33e-05 | 1000 | 214 | 26 | int:SMC5 |
| Interaction | SUPT5H interactions | DCAF6 HIVEP1 CHD3 CHD4 BLM ZFYVE9 GSE1 ATXN1 SYNE2 DSCAM BICRA PPIA NCOR2 SETD5 RPA2 | 3.28e-05 | 408 | 214 | 15 | int:SUPT5H |
| Interaction | PAX2 interactions | 3.38e-05 | 85 | 214 | 7 | int:PAX2 | |
| Interaction | GSC interactions | 3.93e-05 | 87 | 214 | 7 | int:GSC | |
| Interaction | ELK3 interactions | 4.30e-05 | 120 | 214 | 8 | int:ELK3 | |
| Interaction | SFN interactions | KIAA0408 CYLD TET2 RPS19 PTPN14 ATXN1 ZNF638 COBL PPIE ZBTB33 SASH1 KIF26B PPP1R2 OSBP CCDC88A ANKRD17 USP54 RPA2 HTT AHNAK2 | 5.17e-05 | 692 | 214 | 20 | int:SFN |
| Interaction | GJA1 interactions | ERBB2 USP9X TBC1D2B CHRNA4 ACSL3 JUP PTPN14 ZFYVE9 SYNE2 ANK3 SLC6A15 FNDC3A SEC31A IARS2 CCDC88A KIAA1217 PHACTR4 HTT | 5.38e-05 | 583 | 214 | 18 | int:GJA1 |
| Interaction | AHCY interactions | CYLD JUP ATXN1 AHNAK EVC2 FNDC3A PAPSS2 MTHFD1 ASXL3 UBA6 RPA2 HTT | 7.39e-05 | 293 | 214 | 12 | int:AHCY |
| Interaction | LIMK1 interactions | 7.90e-05 | 97 | 214 | 7 | int:LIMK1 | |
| Interaction | GCM1 interactions | 8.45e-05 | 68 | 214 | 6 | int:GCM1 | |
| Interaction | FHL2 interactions | CYLD POGZ JUP LARP4B ZFYVE9 ATXN1 ZNF638 REV1 ZNF3 NCOR2 MTHFD1 KIAA1217 ANKRD17 HTT | 9.13e-05 | 396 | 214 | 14 | int:FHL2 |
| Interaction | DLG4 interactions | CYLD ERBB2 DCAF6 ADGRB3 SYNE2 KCNAB1 PLPPR2 ADGRL3 ANK2 ANK3 DSCAM DLGAP4 PPIA FTH1 HTT | 9.65e-05 | 449 | 214 | 15 | int:DLG4 |
| Interaction | SP7 interactions | TET2 ZNF536 HIVEP1 CHD3 POGZ GSE1 ATXN1 ZNF638 BICRA ATXN1L ZNF3 NCOR2 | 1.05e-04 | 304 | 214 | 12 | int:SP7 |
| Interaction | VARS1 interactions | CYLD ASXL1 DCAF6 USP9X RPS19 CHD4 ATXN1 AHNAK MLLT6 ADNP RPA2 | 1.11e-04 | 260 | 214 | 11 | int:VARS1 |
| Interaction | BAG2 interactions | CYLD ASXL1 MAPKAPK2 CHD4 BRD8 ATXN1 AHNAK PPIE TOMM40 PPIH EVC2 LRRK1 STIL ADNP PHACTR4 RPA2 EPAS1 HTT | 1.22e-04 | 622 | 214 | 18 | int:BAG2 |
| Interaction | PRSS1 interactions | 1.26e-04 | 73 | 214 | 6 | int:PRSS1 | |
| Interaction | FOXQ1 interactions | 1.34e-04 | 141 | 214 | 8 | int:FOXQ1 | |
| Interaction | KLF3 interactions | 1.70e-04 | 228 | 214 | 10 | int:KLF3 | |
| Interaction | FLOT1 interactions | ERBB2 JUP PTPN14 ZFYVE9 ANK2 ANK3 SLC6A15 IARS2 CCDC88A KIAA1217 PHACTR4 FTH1 USP54 RPA2 HTT | 1.79e-04 | 475 | 214 | 15 | int:FLOT1 |
| Interaction | NPM1 interactions | DDX47 CYLD ASXL1 HIVEP1 HIVEP2 EIF3E RPS19 CHD3 CHD4 NGRN JUP LARP4B PTPN14 GPC3 ATXN1 SYNE2 ZNF638 ANK3 MTHFD1L PPIA CRY1 OSBP GZF1 ISG20L2 RPA2 EPAS1 AHNAK2 | 1.88e-04 | 1201 | 214 | 27 | int:NPM1 |
| Interaction | DNAJA1 interactions | CYLD ASXL1 ERBB2 HIVEP1 RPS19 CHD4 LRP1B ATXN1 CIP2A FNDC3A LRRK1 STIL CRY1 ASXL3 RPA2 HTT | 1.94e-04 | 533 | 214 | 16 | int:DNAJA1 |
| Interaction | TLE3 interactions | TET2 HIVEP1 HIVEP2 BRD8 GSE1 ATXN1 GLI2 MLLT6 ANK3 ATXN1L PPIA NCOR2 RPA2 | 2.02e-04 | 376 | 214 | 13 | int:TLE3 |
| Interaction | MTHFD1 interactions | CYLD ASXL1 ACSL3 AHNAK FNDC3A PAPSS2 CRY1 IARS2 MTHFD1 RPA2 HTT | 2.05e-04 | 279 | 214 | 11 | int:MTHFD1 |
| Interaction | ATXN1L interactions | 2.05e-04 | 150 | 214 | 8 | int:ATXN1L | |
| Interaction | TBR1 interactions | 2.06e-04 | 113 | 214 | 7 | int:TBR1 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 1.12e-05 | 19 | 137 | 4 | 909 | |
| GeneFamily | Acyl-CoA synthetase family | 4.14e-05 | 26 | 137 | 4 | 40 | |
| GeneFamily | Ankyrin repeat domain containing | TRPV2 ANKDD1B ZDHHC13 ANKFY1 ANK2 ANK3 ANKRD50 ANKRD17 ANKRD24 | 9.63e-05 | 242 | 137 | 9 | 403 |
| GeneFamily | Olfactory receptors, family 11 | 6.75e-04 | 23 | 137 | 3 | 159 | |
| GeneFamily | Ubiquitin specific peptidases | 8.54e-04 | 56 | 137 | 4 | 366 | |
| GeneFamily | Fibronectin type III domain containing | 1.39e-03 | 160 | 137 | 6 | 555 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L ZHX3 NRIP1 ASXL1 HIVEP1 HIVEP2 USP9X TOGARAM1 BLM ACSL3 LARP4B ZFYVE9 GSE1 ATXN1 SYNE2 ZNF638 KAZN SASH1 FNDC3A STIL ADNP CRY1 NCOR2 ANKRD17 | 1.75e-07 | 856 | 215 | 24 | M4500 |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP | 6.48e-06 | 200 | 215 | 10 | M8305 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.89e-05 | 180 | 215 | 9 | M8239 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZHX3 NRIP1 HIVEP1 HIVEP2 USP9X BLM ACSL3 LARP4B ZFYVE9 ZNF638 FNDC3A STIL CRY1 ANKRD17 | 3.39e-05 | 466 | 215 | 14 | M13522 |
| Coexpression | MENON_FETAL_KIDNEY_5_PROXIMAL_TUBULE_CELLS | 3.96e-05 | 112 | 215 | 7 | M39255 | |
| Coexpression | GSE10325_CD4_TCELL_VS_MYELOID_UP | 4.16e-05 | 199 | 215 | 9 | M3078 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SECISBP2L CYLD TBC1D2B FAXC CHD3 LRP1B CHRNA4 GSE1 KLHL13 BLID ADGRL3 PDZRN4 ANK2 ANK3 DSCAM PILRB SLC6A15 FRY PIEZO2 CCDC88A ASXL3 RAI1 AHNAK2 | 4.31e-05 | 1106 | 215 | 23 | M39071 |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP | 4.33e-05 | 200 | 215 | 9 | M8312 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN | 4.33e-05 | 200 | 215 | 9 | M7205 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_DC_DN | 4.33e-05 | 200 | 215 | 9 | M4484 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 5.28e-05 | 159 | 215 | 8 | MM760 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 ABCA13 OBSCN LRP1B USH2A ADGRL3 KIF26B PIEZO2 GUCY2F ASXL3 MYO15A OTOG | 1.52e-10 | 184 | 221 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 ABCA13 OBSCN LRP1B USH2A ADGRL3 KIF26B PIEZO2 GUCY2F ASXL3 MYO15A OTOG | 1.52e-10 | 184 | 221 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 ABCA13 OBSCN LRP1B USH2A ADGRL3 KIF26B PIEZO2 GUCY2F ASXL3 MYO15A OTOG | 1.52e-10 | 184 | 221 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ERBB2 ABCA13 JUP PTPRZ1 AHNAK SYNE2 ZDHHC13 ANK3 MUC16 KIAA1217 EPAS1 AHNAK2 | 3.97e-10 | 200 | 221 | 12 | ecbe89ff95d046155b984c8c150e0b9e7278f839 |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | ERBB2 ABCA13 JUP PTPRZ1 AHNAK SYNE2 ZDHHC13 ANK3 KIAA1217 EPAS1 AHNAK2 | 5.39e-09 | 200 | 221 | 11 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ERBB2 ABCA13 PLEKHH1 JUP ANK3 MUC16 KIAA1217 UBA6 USP54 RAI1 | 2.33e-08 | 179 | 221 | 10 | 6e965e424eebef50f0202cff75f458be395cfca1 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | SECISBP2L LARP4B PTPN14 SYNE2 SORCS2 GPLD1 ANK3 KIAA1217 USP54 | 1.88e-07 | 170 | 221 | 9 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.88e-07 | 170 | 221 | 9 | 97df5ffb328196c46568975d2d97722bcc753bf5 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | ZNF536 ADGRB3 PTPRZ1 AHNAK COBL ADGRL3 ANK3 KIAA1217 PHACTR4 | 3.05e-07 | 180 | 221 | 9 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | ZNF536 ADGRB3 PTPRZ1 AHNAK ADGRL3 ANK3 KIAA1217 PHACTR4 FTH1 | 3.20e-07 | 181 | 221 | 9 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-07 | 185 | 221 | 9 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-07 | 185 | 221 | 9 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-07 | 191 | 221 | 9 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-07 | 191 | 221 | 9 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA13 OBSCN CAPN13 PTPRZ1 KCNJ15 SORCS2 SLC6A15 ASXL3 EPAS1 | 7.09e-07 | 199 | 221 | 9 | 94a7867e800df352731796de8c24cba133c29622 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.39e-07 | 200 | 221 | 9 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.39e-07 | 200 | 221 | 9 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.39e-07 | 200 | 221 | 9 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.39e-07 | 200 | 221 | 9 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.39e-07 | 200 | 221 | 9 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.39e-07 | 200 | 221 | 9 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.93e-06 | 167 | 221 | 8 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 1.93e-06 | 167 | 221 | 8 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.02e-06 | 168 | 221 | 8 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 2.02e-06 | 168 | 221 | 8 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.21e-06 | 170 | 221 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.11e-06 | 178 | 221 | 8 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.11e-06 | 178 | 221 | 8 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.11e-06 | 178 | 221 | 8 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-06 | 179 | 221 | 8 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 181 | 221 | 8 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-06 | 182 | 221 | 8 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-06 | 184 | 221 | 8 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-06 | 186 | 221 | 8 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.31e-06 | 186 | 221 | 8 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-06 | 187 | 221 | 8 | 7b24a324335c30c4b37795c43611b297274c804b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-06 | 188 | 221 | 8 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-06 | 189 | 221 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.23e-06 | 191 | 221 | 8 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | CF-Myeloid-Monocyte|Myeloid / Disease state, Lineage and Cell class | 5.44e-06 | 192 | 221 | 8 | da55719454b800b7e0cd6d5afd6332ecc5553218 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.65e-06 | 193 | 221 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.65e-06 | 193 | 221 | 8 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-06 | 194 | 221 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.09e-06 | 195 | 221 | 8 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.09e-06 | 195 | 221 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 6.09e-06 | 195 | 221 | 8 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.09e-06 | 195 | 221 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 6.33e-06 | 196 | 221 | 8 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.57e-06 | 197 | 221 | 8 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.57e-06 | 197 | 221 | 8 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.57e-06 | 197 | 221 | 8 | 8c24ffcd417da42fa9bcbe6bd0325360e537303f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.82e-06 | 198 | 221 | 8 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.82e-06 | 198 | 221 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 6.82e-06 | 198 | 221 | 8 | 6333e46cd1ccf5841ce15aea98a4b2f5e3ae4675 | |
| ToppCell | medial-2-Hematologic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.07e-06 | 199 | 221 | 8 | 37b24ec301c99a4383f0217bc92e911ae43f8162 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.07e-06 | 199 | 221 | 8 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | Transplant_Alveoli_and_parenchyma|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.07e-06 | 199 | 221 | 8 | 44bd36a62f06058c5d09feec6e96ecaf310f4791 | |
| ToppCell | medial-Hematologic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.07e-06 | 199 | 221 | 8 | a8345d542098d3579dba0077ec1b5975cb87d0b7 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.07e-06 | 199 | 221 | 8 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.07e-06 | 199 | 221 | 8 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.33e-06 | 200 | 221 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.33e-06 | 200 | 221 | 8 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.33e-06 | 200 | 221 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.33e-06 | 200 | 221 | 8 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.33e-06 | 200 | 221 | 8 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.33e-06 | 200 | 221 | 8 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.33e-06 | 200 | 221 | 8 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.33e-06 | 200 | 221 | 8 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.43e-05 | 158 | 221 | 7 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.43e-05 | 158 | 221 | 7 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.43e-05 | 158 | 221 | 7 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.55e-05 | 160 | 221 | 7 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.75e-05 | 163 | 221 | 7 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.96e-05 | 166 | 221 | 7 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.96e-05 | 166 | 221 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 2.04e-05 | 167 | 221 | 7 | 3ae46c6363da76c8e1f5579e6027bf88ed637a44 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.12e-05 | 168 | 221 | 7 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-05 | 169 | 221 | 7 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 2.38e-05 | 171 | 221 | 7 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.47e-05 | 172 | 221 | 7 | 968d18ab8c3cdeb7936a2aa721a7f41525763863 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 176 | 221 | 7 | 5201f003192c033655ba47f0faf8c47a96eae03d | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 2.86e-05 | 176 | 221 | 7 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-05 | 177 | 221 | 7 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-05 | 177 | 221 | 7 | 0d894a14ddbb2734557743e9efdb89cee5c26769 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-05 | 177 | 221 | 7 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-05 | 177 | 221 | 7 | 6d86b2f97426b552dff5ce6ddf0ead1285ed618e | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-05 | 177 | 221 | 7 | d8b1bbc224d062a57a6ad40b4b2af5d6e0fe63b3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.07e-05 | 178 | 221 | 7 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-05 | 179 | 221 | 7 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.18e-05 | 179 | 221 | 7 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 180 | 221 | 7 | 16728b9a1c52097e3a460534be71a476ecc54f0f | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-05 | 180 | 221 | 7 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-05 | 180 | 221 | 7 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-05 | 180 | 221 | 7 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-05 | 180 | 221 | 7 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 3.42e-05 | 181 | 221 | 7 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.42e-05 | 181 | 221 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.54e-05 | 182 | 221 | 7 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.54e-05 | 182 | 221 | 7 | 1969f729a835a42466b0966be97e25c7b6083649 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-05 | 183 | 221 | 7 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| Disease | Colorectal Carcinoma | TET2 CYP1A2 ABCA13 OBSCN CLSTN2 GSE1 ZNF480 PZP PLPPR2 PDZRN4 TBX22 EVC2 ANK2 MTHFD1L OSBP OVGP1 ABCA5 PUS10 CTBP1 | 5.25e-07 | 702 | 205 | 19 | C0009402 |
| Disease | Carcinoma, Basal Cell | 1.60e-06 | 29 | 205 | 5 | C4721806 | |
| Disease | Congenital muscular dystrophy (disorder) | 6.51e-06 | 6 | 205 | 3 | C0699743 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 9.71e-06 | 148 | 205 | 8 | C0279702 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.28e-05 | 128 | 205 | 7 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.28e-05 | 128 | 205 | 7 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.28e-05 | 128 | 205 | 7 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.28e-05 | 128 | 205 | 7 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.28e-05 | 128 | 205 | 7 | C0007134 | |
| Disease | Pigmented Basal Cell Carcinoma | 4.06e-05 | 28 | 205 | 4 | C1368275 | |
| Disease | Neurodevelopmental Disorders | 4.82e-05 | 93 | 205 | 6 | C1535926 | |
| Disease | intermittent claudication (implicated_via_orthology) | 1.43e-04 | 3 | 205 | 2 | DOID:3669 (implicated_via_orthology) | |
| Disease | Polydactyly | 1.72e-04 | 117 | 205 | 6 | C0152427 | |
| Disease | renal cell carcinoma | 2.06e-04 | 42 | 205 | 4 | EFO_0000681 | |
| Disease | testosterone measurement | TET2 ZHX3 ZNF536 FAXC METAP1 CEP68 SYNE2 ANKDD1B KAZN USH2A SFTA2 ANK2 ANK3 DSCAM DLGAP4 AKNA NCOR2 MTHFD1 MYO15A EPAS1 RAI1 | 2.34e-04 | 1275 | 205 | 21 | EFO_0004908 |
| Disease | Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease | 2.86e-04 | 4 | 205 | 2 | C1301365 | |
| Disease | pulse pressure measurement | TET2 NRIP1 ETFB POGZ SUCLA2 CEP68 JUP ATXN1 JAG1 SULT6B1 ZNF638 FER1L5 ANK2 DSCAM DLGAP4 CNTRL PCDHA2 PIEZO2 KANSL1 KIAA1217 PHACTR4 CPXM1 | 2.93e-04 | 1392 | 205 | 22 | EFO_0005763 |
| Disease | mean platelet volume | TET2 HIVEP2 MAZ SULT1C4 ACSL1 ACSL3 BRD8 GSE1 CDIPT SYNE2 VWF STIL PPIA PPIF FRY DDHD1 HTT TGS1 | 2.94e-04 | 1020 | 205 | 18 | EFO_0004584 |
| Disease | Acute Promyelocytic Leukemia | 2.94e-04 | 46 | 205 | 4 | C0023487 | |
| Disease | prostate specific antigen measurement | 3.59e-04 | 188 | 205 | 7 | EFO_0004624 | |
| Disease | urate measurement, bone density | ADGRB3 LARP4B GSE1 GLI2 KAZN USH2A DSCAM MTHFD1L RDH14 SEC31A HEATR6 FEZF1 PDZD2 | 4.23e-04 | 619 | 205 | 13 | EFO_0003923, EFO_0004531 |
| Disease | Myelodysplastic syndrome | 4.74e-04 | 5 | 205 | 2 | cv:C3463824 | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.74e-04 | 5 | 205 | 2 | 614286 | |
| Disease | chronic myelomonocytic leukemia (is_implicated_in) | 4.74e-04 | 5 | 205 | 2 | DOID:0080188 (is_implicated_in) | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 6.70e-04 | 57 | 205 | 4 | DOID:10652 (implicated_via_orthology) | |
| Disease | spina bifida (is_implicated_in) | 7.07e-04 | 6 | 205 | 2 | DOID:0080016 (is_implicated_in) | |
| Disease | platelet component distribution width | CYP1A2 NRIP1 HIVEP2 ACSL3 CEP68 BRD8 GSE1 ANKDD1B VWF LMAN1L NCOR2 DDHD1 EPAS1 TGS1 | 8.67e-04 | 755 | 205 | 14 | EFO_0007984 |
| Disease | invasive lobular carcinoma (is_marker_for) | 9.86e-04 | 7 | 205 | 2 | DOID:3457 (is_marker_for) | |
| Disease | severe acute respiratory syndrome, COVID-19 | USP9X SUCLA2 LRP1B GLI2 SORCS2 TOMM40 ADGRL3 MTHFD1L KIAA1217 PDZD2 | 1.21e-03 | 447 | 205 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | neural tube defect (is_implicated_in) | 1.31e-03 | 8 | 205 | 2 | DOID:0080074 (is_implicated_in) | |
| Disease | Attached earlobe | 1.31e-03 | 8 | 205 | 2 | HP_0009907 | |
| Disease | body weight | SECISBP2L TET2 HIVEP1 HIVEP2 ADGRB3 LRP1B ACSL3 PTPN14 GSE1 KCNJ15 ZNF638 KAZN PDZRN4 TBX22 FEZF1 ASXL3 KIAA1217 EPAS1 PDZD2 | 1.34e-03 | 1261 | 205 | 19 | EFO_0004338 |
| Disease | sleep quality | 1.43e-03 | 118 | 205 | 5 | EFO_0005272 | |
| Disease | stomach cancer (is_implicated_in) | 1.61e-03 | 72 | 205 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | underweight body mass index status | 1.67e-03 | 9 | 205 | 2 | EFO_0005936 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.67e-03 | 9 | 205 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (16:0_20:5) in blood serum | 1.67e-03 | 9 | 205 | 2 | OBA_2045077 | |
| Disease | coffee consumption measurement | 1.77e-03 | 182 | 205 | 6 | EFO_0006781 | |
| Disease | non-small cell lung carcinoma | 1.87e-03 | 75 | 205 | 4 | EFO_0003060 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.87e-03 | 75 | 205 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Head and Neck Carcinoma | 2.08e-03 | 10 | 205 | 2 | C3887461 | |
| Disease | IGF-1 measurement | ZHX3 ZNF536 EIF3E METAP1 STARD9 SYNE2 SORCS2 TCF23 OSBP EPAS1 | 2.31e-03 | 488 | 205 | 10 | EFO_0004627 |
| Disease | nitric oxide exhalation measurement | 2.33e-03 | 38 | 205 | 3 | EFO_0005536 | |
| Disease | memory performance | 2.36e-03 | 409 | 205 | 9 | EFO_0004874 | |
| Disease | Neoplasm Recurrence, Local | 2.51e-03 | 39 | 205 | 3 | C0027643 | |
| Disease | nucleus accumbens volume change measurement | 2.54e-03 | 11 | 205 | 2 | EFO_0021493 | |
| Disease | pyruvate measurement | 2.80e-03 | 268 | 205 | 7 | EFO_0010117 | |
| Disease | colonic neoplasm | 2.90e-03 | 41 | 205 | 3 | EFO_0004288 | |
| Disease | response to anticonvulsant | 2.95e-03 | 85 | 205 | 4 | GO_0036277 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.03e-03 | 12 | 205 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | cleft palate (is_implicated_in) | 3.03e-03 | 12 | 205 | 2 | DOID:674 (is_implicated_in) | |
| Disease | hepatocyte growth factor measurement | 3.55e-03 | 44 | 205 | 3 | EFO_0006903 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 3.56e-03 | 13 | 205 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | tetralogy of Fallot (is_implicated_in) | 3.56e-03 | 13 | 205 | 2 | DOID:6419 (is_implicated_in) | |
| Disease | Schizophrenia | CYP1A2 NRIP1 ABCA13 CHD4 CHRNA4 PTPRZ1 JAG1 ZNF480 ANK3 LAMA2 ADNP PPIA MTHFD1 RAI1 | 3.65e-03 | 883 | 205 | 14 | C0036341 |
| Disease | uric acid measurement | TET2 ZHX3 PLEKHH1 LARP4B JAG1 DSCAM RDH14 ANKRD50 ORC4 SLC41A1 EPAS1 | 3.77e-03 | 610 | 205 | 11 | EFO_0004761 |
| Disease | cleft lip | 3.85e-03 | 284 | 205 | 7 | EFO_0003959 | |
| Disease | MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K | 4.14e-03 | 14 | 205 | 2 | C1836373 | |
| Disease | Pneumoconiosis | 4.14e-03 | 14 | 205 | 2 | C0032273 | |
| Disease | Bagassosis | 4.14e-03 | 14 | 205 | 2 | C0004681 | |
| Disease | alpha-Dystroglycanopathies | 4.14e-03 | 14 | 205 | 2 | C2936406 | |
| Disease | Neoplasm of lung | 4.14e-03 | 14 | 205 | 2 | cv:C0024121 | |
| Disease | lobe size | 4.14e-03 | 14 | 205 | 2 | EFO_0007666 | |
| Disease | Fukuyama Type Congenital Muscular Dystrophy | 4.14e-03 | 14 | 205 | 2 | C0410174 | |
| Disease | atrial fibrillation (is_implicated_in) | 4.14e-03 | 14 | 205 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | thalamus volume change measurement | 4.14e-03 | 14 | 205 | 2 | EFO_0021496 | |
| Disease | Lung cancer | 4.14e-03 | 14 | 205 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 4.14e-03 | 14 | 205 | 2 | 211980 | |
| Disease | lysophosphatidylcholine 15:0 measurement | 4.14e-03 | 14 | 205 | 2 | EFO_0020941 | |
| Disease | Muscle eye brain disease | 4.14e-03 | 14 | 205 | 2 | C0457133 | |
| Disease | Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1 | 4.14e-03 | 14 | 205 | 2 | C4284790 | |
| Disease | Walker-Warburg congenital muscular dystrophy | 4.75e-03 | 15 | 205 | 2 | C0265221 | |
| Disease | hepatoblastoma (is_marker_for) | 4.75e-03 | 15 | 205 | 2 | DOID:687 (is_marker_for) | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 4.75e-03 | 15 | 205 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | unipolar depression, cognitive function measurement | 4.75e-03 | 15 | 205 | 2 | EFO_0003761, EFO_0008354 | |
| Disease | unipolar depression, bipolar disorder | 4.77e-03 | 156 | 205 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 4.81e-03 | 49 | 205 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | antibody measurement | 4.81e-03 | 49 | 205 | 3 | EFO_0004556 | |
| Disease | alkaline phosphatase measurement | TET2 ZHX3 CHD3 METAP1 NGRN AHNAK TOMM40 PDZRN4 GPLD1 ATXN1L PPIF TNFSF11 KANSL1 STKLD1 RAI1 | 5.07e-03 | 1015 | 205 | 15 | EFO_0004533 |
| Disease | glucose measurement | 5.29e-03 | 380 | 205 | 8 | EFO_0004468 | |
| Disease | executive function measurement, unipolar depression, cognitive function measurement | 5.39e-03 | 51 | 205 | 3 | EFO_0003761, EFO_0008354, EFO_0009332 | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 5.41e-03 | 16 | 205 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | household income | 5.55e-03 | 304 | 205 | 7 | EFO_0009695 | |
| Disease | suntan | 5.86e-03 | 103 | 205 | 4 | EFO_0004279 | |
| Disease | esophageal carcinoma, gastric carcinoma | 6.10e-03 | 17 | 205 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | 6.10e-03 | 17 | 205 | 2 | EFO_0008011 | |
| Disease | MHPG measurement, 5-HIAA measurement | 6.10e-03 | 17 | 205 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | Fetal Alcohol Syndrome | 6.10e-03 | 17 | 205 | 2 | C0015923 | |
| Disease | DNA methylation | ZHX3 ABCA13 LRP1B ACSL1 KAZN USH2A EVC2 SASH1 MTHFD1L ANKRD50 FRY | 6.43e-03 | 656 | 205 | 11 | GO_0006306 |
| Disease | neuroticism measurement, cognitive function measurement | TET2 ASXL1 HIVEP1 LRP1B ZNF638 DSCAM PCDHA2 ASXL3 KIAA1217 RAI1 | 6.49e-03 | 566 | 205 | 10 | EFO_0007660, EFO_0008354 |
| Disease | congestive heart failure (biomarker_via_orthology) | 6.69e-03 | 107 | 205 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | peritonsillar abscess | 6.83e-03 | 18 | 205 | 2 | EFO_0007429 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STLGQGVHSPLMKAQ | 11 | Q6ZRP5 | |
| LRDANTNRKGPMHGS | 256 | Q6ZR03 | |
| ALLGHSGTGKSTLMN | 511 | Q8WWZ7 | |
| SGTTGIPKGVMLSHD | 231 | Q5FVE4 | |
| KMTPGHLLVSVGQFR | 296 | Q2TAA5 | |
| TTKATGRMNSHLAPP | 206 | Q96MC4 | |
| EPMHGSLAGVKLSSQ | 1086 | Q9H2P0 | |
| IPLHGQMSQSKRLGS | 291 | Q9H0S4 | |
| GMGAAKGLQSLPTHD | 1091 | P04626 | |
| AHKVSGMASRLLGPS | 816 | Q99814 | |
| AKARSLSVQHMSSPG | 461 | P43681 | |
| GASAGTHKRMPALSA | 436 | P55198 | |
| NKDPISHSGGMLRAV | 556 | P55198 | |
| TTDMHTSVPRVKGGQ | 241 | Q9Y6F7 | |
| KLGTGEMNIHSPSDV | 821 | Q7Z7A1 | |
| MGSSHLLNKGLPLGV | 1 | Q13363 | |
| TIGKHLDMGSPQLRT | 426 | Q76N32 | |
| MATGTGKHKLLSTGP | 1 | Q9H0E9 | |
| RAGQMSEPHSGLTLK | 1061 | O60242 | |
| GNPKGAMVTHRNIVS | 281 | P33121 | |
| LSEAPGGKKSLSMLH | 976 | Q14687 | |
| GARFSQPSALKTHMR | 441 | Q9H116 | |
| KFPENMGHGSTIQLS | 701 | Q9HAR2 | |
| EKVLQSHMSLPATRG | 511 | O75843 | |
| MKRIPFVLSANLHGG | 486 | Q96SM3 | |
| QGSLLQKTLTGMGHS | 361 | Q86UQ4 | |
| LQGAGHSKLQVTMPG | 236 | Q09666 | |
| SMKVHAPGLNLSGVG | 5321 | Q09666 | |
| RMKGSPSEHGSQQSI | 491 | Q6MZZ7 | |
| GRTPLLAAASMGHAS | 781 | Q9ULJ7 | |
| IHLSGGGLSTKMSIQ | 356 | Q8N6Q3 | |
| GTTGMVARFIPSHLN | 236 | Q58WW2 | |
| ATKNGPTHMELNGSV | 536 | Q8TF21 | |
| DITPLMAAANGGHVK | 301 | O75179 | |
| LANMGSLSQTPGHKA | 181 | P54253 | |
| GSESHKMIDLSGNPV | 116 | O14735 | |
| HGSLASLTIRPGKME | 516 | Q9H4D0 | |
| VATVRALKMHGGGPS | 741 | Q6UB35 | |
| MKGLGDSRPRHLSDS | 1 | Q9Y2H0 | |
| RKGQGRGPHMLSTAV | 1036 | Q2TAZ0 | |
| KGATLQHRMLPSGLS | 1196 | Q96BY7 | |
| VPLTKDQSHGSLRMG | 1136 | Q8IXJ9 | |
| SLRMGSLHGLGKNSG | 1146 | Q8IXJ9 | |
| EVGGTAHTMPNKALV | 2001 | Q9C0F0 | |
| LSSTMHLGPVVSKAL | 1666 | Q7Z5J4 | |
| MAKGVIVRSGTHTLP | 496 | P20742 | |
| QELMTHGAKSPDGTR | 1011 | Q6ZMN7 | |
| KLRHSAPGLLSMANS | 101 | O43447 | |
| ALVHTGPGMNLKDSA | 291 | Q96DM1 | |
| HLSPGKSVLIMDGAS | 141 | O95825 | |
| TLGKNPHLALSRMSQ | 56 | P05177 | |
| GTPSMSGHCKISLKL | 326 | Q9Y5H9 | |
| LARTKNGLSPLHMAA | 326 | Q01484 | |
| KGVLNMSLTPSQGTH | 316 | P53677 | |
| KGRTPLHVSIMAGNE | 366 | Q9P2R3 | |
| IGPRGSGKTMLINHA | 66 | O43929 | |
| MGPKLSTLDATVFGH | 281 | Q5TGI0 | |
| MNLRKSGTLGHPGSL | 76 | Q16595 | |
| LPKISHLTGTATMSQ | 936 | Q8WXI7 | |
| RPSVLHNTGMKGIIT | 1871 | Q9Y618 | |
| HNTGMKGIITAVEPS | 1876 | Q9Y618 | |
| HGGKVLSMAPGLTSV | 531 | O95340 | |
| KHTGSGILSMANAGP | 91 | A0A0B4J2A2 | |
| VLKAVLGMPSSTGRH | 236 | Q8NH07 | |
| SPGLGHSTGMQKIET | 276 | Q8NH07 | |
| KRHSLAMPGETVLNG | 256 | Q674X7 | |
| AEAMATALGIPSGKH | 651 | Q674X7 | |
| LSQHPNIVGMKDSGG | 186 | Q86XE5 | |
| HPSIMRSTLTGKNAQ | 2341 | Q9NZR2 | |
| HPLGMSESEQALKGT | 111 | P53582 | |
| NHGLAISPGMKTRIR | 266 | P49137 | |
| KLLPAGHSVSGSLLM | 161 | Q9NPE2 | |
| TRNTNDPGVGSKHLM | 396 | Q86T24 | |
| RDSSFIPLGHMLTQK | 1351 | Q38SD2 | |
| ILKGQMTHLAAAPGT | 2616 | Q9UKN7 | |
| GNVHSPLKLLTSMAI | 556 | P51654 | |
| TTGMPHRNLGKSGLR | 86 | Q14722 | |
| GRGGHLSMSLNKDSA | 366 | Q9HAT1 | |
| PSHFMKGAIIQLATG | 466 | P0C7T5 | |
| VSSRLHAGKDGTMPR | 1691 | Q2KJY2 | |
| GKDSAHLMNGPISQT | 21 | Q92615 | |
| HPSTMAFSVREGIKG | 386 | Q86SJ6 | |
| GSPGMKRTESRQHLS | 236 | Q3V6T2 | |
| NLKGNSIHMVTGLDP | 161 | Q53EV4 | |
| RQGAPGNHSKALEMT | 1351 | O15018 | |
| IGMSSTPLVKHTAGA | 6 | Q99712 | |
| LKHMGSIQAPTGDTA | 1136 | Q6AI08 | |
| MVGTGPKGHVSSLAR | 186 | Q9H9L3 | |
| LKGGMTNCTLPHRSL | 201 | Q7Z3B3 | |
| STTGLVRQMQGHLSP | 516 | Q6ZU52 | |
| SSGHLSPQVERKMSA | 416 | Q86UK5 | |
| IHTGAKAGRVPSGAM | 211 | P56270 | |
| HVGQSGTKVMSEPLS | 221 | P48552 | |
| QLPKGMSSHLNGQAR | 316 | P48552 | |
| APSAGGLQLRKHMTT | 711 | P10070 | |
| SGDTHTMIPTKINDG | 2831 | P24043 | |
| MTEKLNVSHTGVPLG | 271 | Q8NAT1 | |
| GSKTVLRSPHMNLSG | 541 | P23471 | |
| KHTGSGILSMANAGP | 91 | P0DN26 | |
| AILKALGGHMTTLSG | 306 | Q9NX62 | |
| ITMPENLGHKRTGSN | 366 | P22059 | |
| AMLKNGHTTPIGNAR | 101 | Q8IZ21 | |
| AGGMQALGKHLTSNS | 351 | P14923 | |
| SHLCLPMSSLIAGKG | 186 | O95800 | |
| MAASTASHRPIKGIL | 1 | P41236 | |
| KHTGSGILSMANAGP | 91 | A0A075B759 | |
| LEAKMRHGFSGIPIT | 131 | P20839 | |
| MAGGRPHLKRSFSII | 1 | Q96GM1 | |
| KDGQPLTASAHIRMT | 5296 | Q5VST9 | |
| KHTGSGILSMANAGP | 91 | F5H284 | |
| KHTGSGILSMVNAGP | 91 | A0A075B767 | |
| KHTGSGILSMANAGP | 91 | Q9Y536 | |
| KHTGSGILSMANAGP | 91 | P0DN37 | |
| TQPKHLSASMGGSVE | 36 | Q9UKJ1 | |
| HGDFGRTKPNIGSLM | 491 | Q3MIT2 | |
| DHVTNLRKMGAPESG | 151 | P02794 | |
| GIMASGRKAVTHAIP | 1526 | P42858 | |
| EMGLSSHLQSSKAGP | 51 | Q9P2N7 | |
| HSSSQGMRNIKHVGP | 1091 | P54132 | |
| HLVVRPGLGSKAGSM | 1206 | Q12873 | |
| LNSLGAGPFSHMIKL | 931 | Q9Y2H6 | |
| HLMLARKGDSQTPGL | 321 | Q8ND61 | |
| MVASGLPKRNGSRHA | 936 | P51841 | |
| PTSALQIEGKGSHIM | 6 | Q53FE4 | |
| RNGDLGAMKHSPGLS | 131 | Q6P2H3 | |
| QTHLLKQGRSSMGTG | 546 | Q16526 | |
| RKSTMVSLPLGSGSH | 361 | O75128 | |
| IHTGMVPQGTKVLSF | 486 | Q7Z591 | |
| TKNGLSPLHMATQGD | 331 | Q12955 | |
| SKLGHVVMGNNAVSP | 386 | P60228 | |
| RLHGLKASSMTQTPA | 596 | Q8NEL9 | |
| AKPSIMSPGHLRAST | 926 | Q5TBA9 | |
| ERQLSGSTPSLNKMH | 2501 | Q5TBA9 | |
| HSLSASMPILQESKG | 3541 | Q8NDH2 | |
| RAHSPILNMEGTKIG | 331 | P48728 | |
| FSLTKMPNTNGSIGH | 421 | Q9NQC7 | |
| NLGSSAMKRNVPGHV | 71 | Q8IZY5 | |
| GALSKPMSVHLLNQG | 441 | Q9NZM4 | |
| HLVVRPGLGSKTGSM | 1196 | Q14839 | |
| LKHTGPGLLSMANSG | 226 | Q9UNP9 | |
| VRALKMHGGGPTVTA | 701 | P11586 | |
| SPGLGHSTGMQKIET | 276 | Q8NG94 | |
| VLKAVLGMPSSTGRH | 236 | B2RN74 | |
| SPGLGHSTGMQKIET | 276 | B2RN74 | |
| SVGHQSMTPGEKALT | 481 | Q12889 | |
| IIEKASHSGMINPSR | 151 | P78504 | |
| PLMTKAVTVRGHGSL | 1626 | Q6ZRI0 | |
| GHISPKSRPMANSTL | 51 | O95157 | |
| MLANHLLGSKSISFG | 81 | Q9P1Q5 | |
| PILKGGSHRISQMIT | 446 | O60469 | |
| KSMNTLVPVASHNRG | 426 | P0C091 | |
| ATGSRDPSMKAHIGA | 231 | P59535 | |
| SIPGFLISSGMSSHK | 296 | Q5H9L4 | |
| VTHKGIPMAASNLSV | 291 | Q14242 | |
| ENHMGLADTKIPRSG | 5096 | O75445 | |
| HPAMLSKVLGGSFAD | 1706 | Q93008 | |
| NGSIDGIRHMFTPKL | 276 | Q9H2J7 | |
| AMRAKSQDTHGAVGP | 241 | Q6IMI4 | |
| GVMPSHFSRGSKSVA | 86 | P39019 | |
| ENFILKHTGPGILSM | 86 | P62937 | |
| IHMTLQPTAGGTSKN | 1036 | Q8WXH0 | |
| SQKLMVPGSTAHRAL | 146 | A0AVI2 | |
| SGTTGLPKAAMITHQ | 226 | O14975 | |
| MLKQAGSGVHAAGTP | 536 | P57071 | |
| LNSKQAFSMPHGGSL | 6 | Q12837 | |
| HNATTKMLATAPARG | 6 | A0PJY2 | |
| MLTTRGHGPAETQTL | 151 | Q8TDQ0 | |
| HGSQRTSGPESSMKV | 346 | Q7Z3K3 | |
| RTGVVTDGVKHSMNP | 26 | P38117 | |
| LRHGPAKAISMSRTD | 781 | Q15678 | |
| TVHTKDTAPGLIMGA | 516 | Q96PQ0 | |
| AGTPHVSGGKMLSAL | 611 | Q5T5P2 | |
| HGLMKDLSRGSLSPG | 1031 | Q9C0A6 | |
| RLSTAANIGHMDTPK | 156 | Q8IVJ1 | |
| GIGSPMASSTITKIH | 656 | Q93073 | |
| TLKHVGPGVLSMANA | 131 | P30405 | |
| LLPANHVTMAKGTGL | 376 | Q9NSE4 | |
| LPLVNHSSGMLVKCG | 231 | Q9H5K3 | |
| MHGKTVLITGANSGL | 41 | Q9HBH5 | |
| PHQMVSQGLASLRKS | 941 | Q9P2P6 | |
| TMDIIKLHGGTPANF | 331 | Q9P2R7 | |
| PAADSQKLSMGGLHS | 176 | Q96K30 | |
| QPGRHTVSGGSLLMA | 181 | Q8WZ75 | |
| DQLGIHSPGLSKMVS | 266 | Q8TDG2 | |
| LHGTLMTQGDPAKQL | 481 | A6NHY2 | |
| TGLKLHLSTAGMTGD | 5276 | Q8IVF2 | |
| TGLPKGVMISHSNII | 291 | O95573 | |
| AMIHSLSGGKINPET | 886 | Q8TCG1 | |
| MKRGEEIASSGQSPH | 131 | Q7RTV5 | |
| RPLLDSGTMGTKGHT | 586 | A0AVT1 | |
| AQSSPGLHMRKGVSI | 776 | Q15468 | |
| RIHTGEKPLNGIGMS | 416 | P17036 | |
| NGQTPLMLSAHKVIG | 181 | Q8IUH4 | |
| HMVLSKANSQPSAGR | 166 | P15927 | |
| LTSEMHGARPGASKA | 1781 | P04275 | |
| VTNLPGVGHSMESKL | 646 | Q9UBZ9 | |
| GVGHSMESKLASLGI | 651 | Q9UBZ9 | |
| TEAMHLRKSLRQSPG | 236 | Q8NE28 | |
| MAASTASHRPIKGIL | 1 | Q6NXS1 | |
| MPSRLISGSNHLKVN | 481 | Q9Y458 | |
| MKIPSLGSGLEQAHA | 91 | O75897 | |
| KLGTSLSSGHVLMNG | 646 | P80108 | |
| EPTKTTMQGHTGRLL | 46 | Q9H5I5 | |
| PHLKAEVGNSMLLTG | 421 | Q9Y5S1 | |
| VLSGAGNFMDPSKRH | 256 | P13686 | |
| RSLHVGSNNSDPMGK | 416 | O94885 | |
| QGTAPLMFSRRHSLK | 721 | A0A0J9YWL9 | |
| DSVKSQMVRSHLPGG | 181 | Q6BDI9 | |
| TQPKHLSASMGGSVE | 36 | Q9UKJ0 | |
| RGVMTLFSIKSNHPG | 421 | Q99835 | |
| LNQEIGMRKPSHSGF | 1026 | Q9ULM0 | |
| GMKNHEIVPGSLIAS | 26 | Q9BVS4 | |
| TSLSHGIKLVNPMFR | 211 | Q9Y2K6 | |
| VAHLTGKSNSRSMPL | 146 | P48023 | |
| SIKIPSSHTLMKGGS | 246 | O14788 | |
| HQLGPGLRSKMAIQT | 166 | O96008 | |
| LGKLLSPISSMAHGV | 466 | O15090 | |
| KESGMALPQGHLTFR | 16 | Q8WV37 | |
| SSHGTGPGMTLQLKL | 16 | Q6UW10 | |
| VTMHDLKQGLGPSGT | 361 | Q9Y5Q8 | |
| AMPGVGHSQTQAKAR | 11 | Q7RTU1 | |
| VLMPSSAGGRSNHLA | 591 | Q9Y4F4 | |
| SMGLPLQFGRITAHK | 96 | Q96RS0 | |
| GGKLVTFENVRMPSH | 401 | O94979 | |
| TLAAMHRPGTGKLTS | 1706 | P31629 | |
| SHTANGLSKMLPALN | 1791 | Q6N021 | |
| GLSKMLPALNHDRTA | 1796 | Q6N021 | |
| NLKGSRAMIPGDHSS | 551 | Q9H4I2 | |
| ELKNSMSSFRPGRGH | 226 | Q9UPU7 | |
| EAMSVRSKALAQGPH | 931 | P15822 | |
| TKMSGLHISGGQSVL | 291 | Q14966 | |
| KPLFGETGHTIMNLL | 1096 | O95405 | |
| PGLSKTSTAEMEHGL | 1366 | Q70EL1 | |
| SAPGALGTGDLHMTK | 271 | Q96L15 |